MSH6 and PMS2 are both considered to be tumor-suppressor and mismatch repair (MMR) genes (Ripperger and Schlegelberger, 2016; Tabori et al., 2017; Tate et al., 2019). This evidence concerns the gene MRC1 and neoplasm.